Staphylococcus aureus (MRSA) Reduction
- Authors
- Travis R. Farley, Study Director
- Facility
- Microbac Laboratories, Inc.; North Carolina
- Download
- Full Report
Objective
To evaluate the efficacy of the Protect 900 on reducing methicillin-resistant Staphylococcus aureus (MRSA).
Methodology
The challenge bacteria were aerosolized using a six-jet collision nebulizer under high pressure air and introduced into the chamber with the Protect 900.
Summary of Results
The Protect 900 reduced 99.99% of Staphylococcus aureus bacteria over the course of four hours.
